New blog post! Dr Daniel Rosenbaum and Dr Daniel Buchman draw attention to commercial involvement in psychedelic research and to the population health risks associated with this involvement:
https://impactethics.ca/2023/07/20/psychedelics-ethics-and-the-commercial-determinants-of-health/